Background and Aims: High-flow nasal cannula (HFNC) oxygen therapy comprises an air/oxygen blender, an active humidifier, a single heated circuit, and a nasal cannula. It reduction of anatomical dead space, PEEP effect, constant fraction of inspired oxygen, and good humidification. While there have been no big randomized clinical trials comparing reintubation rate in HFNC and conventional oxygen therapy.
Methods: We identified and collected randomized controlled trials (RCTs) which reported the using HFNC and conventional oxygen therapy with reintubation rate from 2009 Jan. to 2017 Dec. in Cochrane Library, PubMed and Clinical Key. We used the keywords of High flow nasal cannula, oxygen therapy and post-extubation. According to risk level to evaluate the validity of studies and so as to Review Manager 5.3 to calculate for risk ratio, mean and standard deviation.
Results: There were 5 RCTs trials with 1117 patients were included to our systematic review. First, HFNC group was associated with decrease the rate of overall reintubation (RR = 1.09, 95% CI = 1.05-1.14, P = 0.45), compared with conventional oxygenation therapy. Second, HFNC group was associated with decrease the rate of overall hypoxemia (RR = 1.36, 95% CI = 0.92-2.00, P = 0.16) and decrease the rate of overall mortality (RR = 1.19, 95% CI = 0.67-2.11, P = 0.89).
Conclusion:
Using high flow nasal cannula compare with general oxygen treatment equipment after extubation, which can significant reduce overall reintubation rate, mortality rate and improve oxygenation. 
Methods:
The intubated adult patients with MV support were enrolled and divided into the UE and non-UE groups. Demographic data, admission unit, MV duration, overall weaning rate and mortality rates were compared. The differences in the clinical features and outcomes of UE in patients admitted to ordinary ward and intensive care unit (ICU) were assessed.
Results: Totally 9245 intubated adult patients were included. UE occurred in 303 (3.5%) patients, and occurred 0.27 times/100 MV days. Old age, non-operation related MV cause, and admission out of the ICU were significant factors associated with UE. UE patients showed a trend of better overall weaning rate (71.9% vs 66.7%, P = .054) than non-UE. The in-hospital mortality rate (25.7% vs 24.8%, P = .713) were similar between the UE and non-UE patients. The reintubation rate of UE patients was 44.1% (142/322). Successful UEs were associated with patients in weaning process (52.8% vs 38.7%, P = .012), and patients received non-invasive positive pressure ventilation (NIPPV) support after UE (19.4% vs 3.5%, P < .001). Patients with successful UE had significantly shorter MV days, lower APACHE II score, higher overall weaning rate, and lower mortality than those with unsuccessful UE. Outcomes of UE occurred in ordinary ward were not different than those in ICU, with similar reintubation rate (41.2% vs 45.5%; P = .472), overall weaning rate (72.5% vs 70.9%; P = .762), and in-hospital mortality rate (27.5% vs 24.1%; P = .518).
Conclusion:
The overall weaning rate and in-hospital mortality rates of the UE and non-UE patients were similar. UE occurred in ordinary ward also had similar outcomes to those in ICU.
